Nu-Med Plus (NUMD) EBIT Growth (5y) (2017 - 2026)
Powered by 
Analysis
Nu-Med Plus (NUMD) EBIT Growth (5y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.29% |
| Dec 31, 2025 | 54.33% |
| Sep 30, 2025 | 53.22% |
| Jun 30, 2025 | 59.05% |
| Mar 31, 2025 | 34.00% |
| Dec 31, 2024 | 46.17% |
| Sep 30, 2024 | 34.66% |
| Jun 30, 2024 | 41.97% |
| Mar 31, 2024 | 45.39% |
| Dec 31, 2023 | 30.28% |
| Sep 30, 2023 | 50.74% |
| Jun 30, 2023 | 32.83% |
| Mar 31, 2023 | 28.32% |
| Dec 31, 2022 | 46.64% |
| Sep 30, 2022 | 15.87% |
| Jun 30, 2022 | 12.20% |
| Mar 31, 2022 | 3.07% |
| Dec 31, 2021 | 17.00% |
| Sep 30, 2021 | 29.83% |
| Jun 30, 2021 | -7.20% |